Herbert K. Parker Purchases 6,100 Shares of TriMas Co. (NASDAQ:TRS) Stock

TriMas Co. (NASDAQ:TRS) Director Herbert K. Parker purchased 6,100 shares of TriMas stock in a transaction dated Monday, May 6th. The stock was bought at an average price of $26.52 per share, with a total value of $161,772.00. Following the acquisition, the director now directly owns 39,157 shares of the company’s stock, valued at $1,038,443.64. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

TriMas Stock Up 1.7 %

Shares of TriMas stock opened at $26.89 on Friday. TriMas Co. has a 52-week low of $22.59 and a 52-week high of $29.07. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.41 and a current ratio of 2.73. The business’s 50 day simple moving average is $25.69 and its 200 day simple moving average is $25.17. The firm has a market cap of $1.10 billion, a PE ratio of 27.72 and a beta of 0.71.

TriMas (NASDAQ:TRS) last announced its quarterly earnings data on Tuesday, April 30th. The industrial products company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The business had revenue of $227.10 million for the quarter, compared to analyst estimates of $220.60 million. TriMas had a net margin of 4.48% and a return on equity of 9.68%. The firm’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.30 earnings per share. On average, analysts predict that TriMas Co. will post 1.92 earnings per share for the current fiscal year.

TriMas Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 14th. Stockholders of record on Tuesday, May 7th will be issued a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Monday, May 6th. TriMas’s payout ratio is 16.49%.

Institutional Trading of TriMas

Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC bought a new position in TriMas in the fourth quarter valued at approximately $205,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of TriMas by 31.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,089 shares of the industrial products company’s stock valued at $225,000 after buying an additional 2,173 shares during the last quarter. Quantbot Technologies LP boosted its holdings in shares of TriMas by 5.7% in the 1st quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock valued at $239,000 after buying an additional 478 shares during the last quarter. Inspire Investing LLC bought a new position in shares of TriMas in the third quarter valued at $308,000. Finally, Handelsbanken Fonder AB increased its holdings in TriMas by 19.8% during the fourth quarter. Handelsbanken Fonder AB now owns 15,095 shares of the industrial products company’s stock worth $382,000 after buying an additional 2,500 shares during the last quarter. Institutional investors own 99.42% of the company’s stock.

Wall Street Analyst Weigh In

Separately, BWS Financial reaffirmed a “buy” rating and issued a $40.00 target price on shares of TriMas in a research note on Wednesday, May 1st.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.